The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Teva Invites the Public to Listen to Its 2012 Investor Meeting Webcast

Thursday, December 06, 2012

Teva Invites the Public to Listen to Its 2012 Investor Meeting Webcast08:39 EST Thursday, December 06, 2012 JERUSALEM (Business Wire) -- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) invites investors and the general public to listen to a live audio webcast of its 2012 Investor Meeting on Tuesday, December 11, 2012 at 12:00 p.m. ET.     What: Teva's 2012 Investor Meeting   Who: Teva Management   When: Tuesday, December 11, 2012 at 12:00 p.m. ET   Where: www.tevapharm.com   How: Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.   About Teva Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $18.3 billion in net revenues in 2011. IR:Kevin C. MannixUnited States215-591-8912Joseph MarczelyUnited States267-468-4281Tomer AmitaiIsrael972 (3) 926-7656orPR:Hadar Vismunski-WeinbergIsrael972 (3) 926-7687Denise BradleyUnited States215-591-8974